CD8A and melanoma: Those include MC38 colon carcinoma, B16F10 melanoma cells, and CMT-64 non-small cell lung cancer cells, whose neoantigenomes have been recently deciphered thus facilitating the analysis of neoepitope-specific CD8 T-cell responses33–35.